{"name":"DaVita Inc.","slug":"davita","ticker":"DVA","exchange":"NYSE","domain":"davita.com","description":"DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.","hq":"Denver, CO","founded":1994,"employees":"78000","ceo":"Javier Rodriguez","sector":"Dialysis & Renal Care","stockPrice":193.41,"stockChange":-4.69,"stockChangePercent":-2.37,"marketCap":"$12.4B","metrics":{"revenue":13835087872,"revenueGrowth":6,"grossMargin":32.5,"rdSpend":0,"netIncome":746803000,"cash":666545984,"dividendYield":0,"peRatio":18.6,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-22","type":"earnings","headline":"DaVita Inc. Reports Fourth Quarter and Full Year 2023 Results","summary":"DaVita Inc. reported its fourth quarter and full year 2023 results, with revenue of $2.9 billion and adjusted EBITDA of $1.1 billion.","drugName":"","sentiment":"neutral"},{"date":"2023-08-01","type":"deal","headline":"DaVita Inc. Acquires Kidney Care Provider","summary":"DaVita Inc. acquired a kidney care provider, expanding its presence in the dialysis market.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNeFduYm05QVU4UWZSQ2o5RzJ3OEdHMW1YVlN0dWhKNWlXX0xFcW4tbDRuQUtXUlpQdUpwNlYzNlFINDAwcW50M2RqZVJTMFB4VUNpRTBfNmRkWnFMMWVpVDJvSVptVUhkZ2J0Vkx6b05pbHVJM3VwbzRhdWE1OXFWTmFfcks3ajNIVkt0aUMxV2FjMVdzSjcySjg1RTFqY2FhSGRIeExBRkRSTWZacUdGaGhpcURkRkI5WV85dThvTVl0bUVpenVwdzltZmpEdllRUlowRG4wMGJ3dTZ2SGJxaFM5c09pLTF0Vml4UnYtMXQxa0tUYTZaZ2FGRE9QX3NzcFY5bmR5b0ZuZndZeGZ4cW0tM1A?oc=5","date":"2026-04-07","type":"earnings","source":"The Globe and Mail","summary":"You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500. - The Globe and Mail","headline":"You'll Never Guess Which Healthcare Stock Delivered the Best First-Quarter Performance in the S&P 500.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxQR3RXVzRFZ3k3ZmFZLWVObWVUZy1CN3M5dEFFWFM0Rmh3RG16VHVHR1lndzA4czg2dW5CbU9jbUlDT1VrYkQzbHQ4bjJuOUNyRzRaUDZRMzdMUnlPbDRLX3VsbEJkQ2c3aGdvUXE2VzRsWW1uOEpZdF9mZzN4TTcybjg3LTB5aS15TF9BU0pVOEhaTDJFMjlJQlhrM09sS0x2WlRqaWt6ZUxLMjRQekVwa2hmemozZVlqVHloeHE5WHhwblR0TzF0R2p0SU5ZN0txOXkzWXI2S0ozYkVrVmZ3V1p0ZTJOcXgyQ2I4ME82V0dqeUUzdmhYMzNteUc?oc=5","date":"2026-04-02","type":"pipeline","source":"TradingView","summary":"AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - TradingView","headline":"AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQeEhGYWk3MGljdkhyWjc3TDJIOGFlcVBxMGFheVRjRm9HMUlpVlUtUFQ1bG1ocW5lQjF5UjFDdVBienpNaEZRRlVoUVlUZk1jWjZBd3dYM3hNWEQwR0tpbzBlUGc2aW9wcVZhYUZGem1NLWJFNU5oUzRjWUtyS0VmR0hXMmZic3hpamdwSUxpYVFaQ0JlemVUbGJscVprU3JyRnlRYW5GNlVOQXZWS2p3SGlQOA?oc=5","date":"2026-03-17","type":"pipeline","source":"Stock Titan","summary":"DaVita backs first-in-class AP306 kidney drug for dialysis patients - Stock Titan","headline":"DaVita backs first-in-class AP306 kidney drug for dialysis patients","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-17","type":"pipeline","source":"The Manila Times","summary":"R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hyperphosphatemia in patients with chronic kidney disease - The Manila Times","headline":"R1 Therapeutics launches with oversubscribed $77.5 million Series A financing to advance first-in-class treatment for hy","sentiment":"neutral"},{"date":"2026-02-11","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: 10-K","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQUFlWRHdrQXQ5MGtxTjJkWXNiSDN0bHNTbWVFNXU5VlhyQjBFME9nQ0xDTXhSeTBvQkpxNHMxODJ2LTgxT0IxOFNZNEF5elFnY3g0UmYzSjlkUjRNbnFiT1NWRG1HemJRUU9OX0hmNi1WSFJxMWNVV1NNRXVaXzRJbHZKRUYzUkdYOFh5aTdJQ2daYWkzc1d1c3hJSmV2YTh0Z3F6OWJxYTMxeU5pSFFZMHoxamdYOHBYaE14azBoQ2RpWG1TYWpVWGNGMjZOZG92N3prZkdVSElYYWQzQ0dURw?oc=5","date":"2026-02-02","type":"regulatory","source":"Reuters","summary":"DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump - Reuters","headline":"DaVita forecasts 2026 profit above estimates on steady dialysis service demand; shares jump","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFBsYzJUNG9pck0zU1kxSzFPbkVadzBCRmZkWWFJTTdMaTVsRFIwdVZObkxMWEs5VVZnM2swVDlzU244bURWRkpaa1FvZnhpMVppTEVJa2N2SWtyOWQ3VFkyWEdYWW9XQTdnVjNCMHZnTEZyRUg1ZWp3?oc=5","date":"2026-01-29","type":"pipeline","source":"Finviz","summary":"3 Healthcare Stocks We Steer Clear Of - Finviz","headline":"3 Healthcare Stocks We Steer Clear Of","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE9zOWhTNVFxUmVoNkg5ZU5jREpIeXNSdnd0NzIxM0U4X3ZjZDEyZ0F4RUFTaFFMUzNaaXlteG5oOUx6S3JYWG9LWU9RNmtLaC10NEFmc1lGOVhybTA?oc=5","date":"2026-01-09","type":"pipeline","source":"Finimize","summary":"DaVita’s Stock Looks Cheap, But The Risks Are Real - Finimize","headline":"DaVita’s Stock Looks Cheap, But The Risks Are Real","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNQUVLNmU5ZHdkME5NeHRCYTFOSW93enRCamE3NWNMT1U4dU9oTWU2NzQ4N0NKMVRlWjd4YU5RTl9taFBsam9ucktIbTNlekttbDNpTEN4RUJtb2pLWnNpQTBHa2Zkek0xMDdJQktvY3cxbTltazluX19mZzRVbUI3YUFZRm92OHNmRWswQXF3Qk9vVEk1ZU0wMC1B?oc=5","date":"2025-12-03","type":"pipeline","source":"Seeking Alpha","summary":"DaVita - More Volatile But Better Upside Than Fresenius (NYSE:DVA) - Seeking Alpha","headline":"DaVita - More Volatile But Better Upside Than Fresenius (NYSE:DVA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNTGhQSnZMRzJJS1VzaFBrUEhxb0NEekJjTXo5TUV0cWg3VS1yTFE2SllybHpfSl8tSVNKRzd6ZTlxNXowS3lreG1GemFyUkJqTEZfNmZ5MVpmVGxKbmdyNDdiTF92VDBCRzBrdHpGbHg2Z0tHdXFlSElHNU8ySmotc3VlcmNXc3VfUTdr?oc=5","date":"2025-11-11","type":"pipeline","source":"Yahoo Finance","summary":"Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know - Yahoo Finance","headline":"Pfizer, Amneal, Jazz Pharmaceuticals, BD, and DaVita Shares Skyrocket, What You Need To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNNnNJS1FRamNkUjZaczZpWUlRUVBnVmttd0VkOFRrVGVwb1Q5V2ZyT0Y5M2dtWENwVWkyOFNNal9UblY1NjRvOVRHSVpxaTVBUnpIZElaNDBWNDRTSnVVTzRDQ3gxd0N6ME1lc21jZjRqTFlmNUV4dE9FQmFrMWFpdElNR1dlVWluU1dKVTF2TWJ0eE4ya0FTYnNpSl9PQ1hEU1RnaHNLWFk0eGcxcE1KY3AtSkZVcG5xSFBsR21tNmJSUG9LV2tnam5vYW94NjJ6eFFab1RTWEdYQ1ZreDFNWEs3R05SMG8?oc=5","date":"2025-08-21","type":"pipeline","source":"Reuters","summary":"Ransomware attack at DaVita impacted 2.7 million people, US health dept website shows - Reuters","headline":"Ransomware attack at DaVita impacted 2.7 million people, US health dept website shows","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNM3k5SGR1dHh1QTZOOWZBRWtqdXQzelktbm9sb1RlNzd1Y0htYXBCbmloeU5fY1pkY3BoZjF1aVhXOG9GMFJVbEhUbGRqV2h6VnRuWXIzekJUZ0xRVTZzOWhjLVlnR05KQUpzcVdtTnYwcEtvRElvUFFTMl8xS2owS3VDTGFZUHFxVnhkcFJzSlBlX2FsV0E?oc=5","date":"2025-08-05","type":"earnings","source":"PR Newswire","summary":"DaVita Inc. 2nd Quarter 2025 Results - PR Newswire","headline":"DaVita Inc. 2nd Quarter 2025 Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxOVkgyN3hRUDY0U2N4emZSUkVOZHdiYTM0RUlrbGtFRDc0VnNTNTg0Yk0tUmxFQnZxb1VLNGU5eS0tNkRERzh1QUhscHo0QjBVMThtanhKdDJDT1B1WlFtVG5pSmNJUnU0c01RWWp3Y3QxSXVxd3FMN2tZM1JmZnd4bXlR?oc=5","date":"2025-03-14","type":"pipeline","source":"Yahoo Finance","summary":"Is DaVita Inc. (DVA) the Best Healthcare Stock For Long-Term Investment? - Yahoo Finance","headline":"Is DaVita Inc. (DVA) the Best Healthcare Stock For Long-Term Investment?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Fresenius Medical Care AG & Co. KGaA","Renal Ventures Management LLC","US Renal Care"],"therapeuticFocus":["Dialysis and Renal Care"],"financials":{"source":"sec_edgar+yahoo","revenue":13643069000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":13643069000,"period":"2025-12-31"},{"value":12815550000,"period":"2024-12-31"},{"value":12815550000,"period":"2024-12-31"},{"value":12140147000,"period":"2023-12-31"},{"value":12140147000,"period":"2023-12-31"}],"grossProfit":4399593000,"grossProfitHistory":[{"period":"2025-12-31","value":4399593000},{"period":"2024-12-31","value":4217029000},{"period":"2023-12-31","value":3820430000},{"period":"2022-12-31","value":3400341000}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":1673630000,"operatingIncome":2010615000,"operatingIncomeHistory":[{"period":"2025-12-31","value":2010615000},{"period":"2024-12-31","value":1954828000},{"period":"2023-12-31","value":1601003000},{"period":"2022-12-31","value":1312542000}],"netIncome":746803000,"netIncomeHistory":[{"period":"2025-12-31","value":746803000},{"period":"2024-12-31","value":936342000},{"period":"2023-12-31","value":691535000},{"period":"2022-12-31","value":560400000}],"eps":9.84,"epsHistory":[{"period":"2025-12-31","value":9.84},{"period":"2024-12-31","value":10.73},{"period":"2023-12-31","value":7.42},{"period":"2022-12-31","value":5.85}],"cash":676438000,"cashHistory":[{"period":"2025-12-31","value":676438000},{"period":"2024-12-31","value":794933000},{"period":"2023-12-31","value":380063000},{"period":"2022-12-31","value":244086000}],"totalAssets":17480103000,"totalLiabilities":16321665000,"totalDebt":12874331000,"equity":-651082000,"operatingCashflow":1886500000,"operatingCashflowHistory":[{"period":"2025-12-31","value":1886500000},{"period":"2024-12-31","value":2022038000},{"period":"2023-12-31","value":2059031000},{"period":"2022-12-31","value":1564570000}],"capex":-575864000,"capexHistory":[{"period":"2025-12-31","value":-575864000},{"period":"2024-12-31","value":-555443000},{"period":"2023-12-31","value":-567985000},{"period":"2022-12-31","value":-603429000}],"freeCashflow":1310636000,"dividendsPaid":null,"buybacks":-1792999000,"employees":78000,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":421914000,"ebit":486365000,"ebitda":664194000,"period":"2026-03-31","revenue":3415548000,"epsBasic":2.93,"netIncome":197530000,"rdExpense":null,"epsDiluted":2.87,"grossProfit":1073291000,"operatingIncome":473548000},{"sga":472362000,"ebit":531011000,"ebitda":717714000,"period":"2025-12-31","revenue":3619787000,"epsBasic":3.36,"netIncome":234217000,"rdExpense":null,"epsDiluted":3.29,"grossProfit":1210270000,"operatingIncome":551205000},{"sga":414373000,"ebit":459360000,"ebitda":636850000,"period":"2025-09-30","revenue":3420227000,"epsBasic":2.09,"netIncome":150332000,"rdExpense":null,"epsDiluted":2.04,"grossProfit":1087468000,"operatingIncome":495605000},{"sga":412805000,"ebit":514990000,"ebitda":689694000,"period":"2025-06-30","revenue":3379526000,"epsBasic":2.62,"netIncome":199337000,"rdExpense":null,"epsDiluted":2.58,"grossProfit":1117986000,"operatingIncome":530477000},{"sga":374090000,"ebit":421388000,"ebitda":597839000,"period":"2025-03-31","revenue":3223529000,"epsBasic":2.05,"netIncome":162917000,"rdExpense":null,"epsDiluted":2,"grossProfit":983869000,"operatingIncome":433328000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-12-31","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":193.41,"previousClose":198.1,"fiftyTwoWeekHigh":202.69,"fiftyTwoWeekLow":101,"fiftyTwoWeekRange":"101.0 - 202.69","fiftyDayAverage":156.87,"twoHundredDayAverage":134.59,"beta":0.84,"enterpriseValue":27075977216,"forwardPE":11.3,"priceToBook":-16.94,"priceToSales":0.9,"enterpriseToRevenue":1.96,"enterpriseToEbitda":9.7,"pegRatio":0.62,"ebitda":2792761088,"ebitdaMargin":20.2,"freeCashflow":999662976,"operatingCashflow":2027321984,"totalDebt":13220841472,"debtToEquity":1261.3,"currentRatio":1.42,"returnOnAssets":7.5,"returnOnEquity":81,"analystRating":"2.8 - Hold","recommendationKey":"hold","numberOfAnalysts":7,"targetMeanPrice":193.71,"targetHighPrice":235,"targetLowPrice":145,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":50.6,"institutionHeldPercent":54.5,"sharesOutstanding":64185000,"floatShares":33852018,"sharesShort":6250931,"shortRatio":9.59,"shortPercentOfFloat":9.5,"epsTrailing":10.38,"epsForward":17.18,"revenuePerShare":194.22,"bookValue":-11.41,"officers":[{"age":54,"name":"Mr. Javier J. Rodriguez","title":"CEO & Executive Director"},{"age":60,"name":"Mr. Joel  Ackerman","title":"CFO & Treasurer"},{"age":57,"name":"Ms. Kathleen Alyce Waters","title":"Chief Legal & Public Affairs Officer"},{"age":56,"name":"Mr. James O. Hearty","title":"Chief Compliance Officer"},{"age":48,"name":"Mr. David P. Maughan","title":"Chief Operating Officer of DaVita Kidney Care"},{"age":null,"name":"Nic  Eliason","title":"Group Vice President of Investor Relations"},{"age":null,"name":"Ms. Stephanie  Hendrickson","title":"Chief People Officer"},{"age":null,"name":"Mr. Misha  Palecek","title":"Chief Transformation Officer of U.S. Kidney Care Business"}],"industry":"Medical Care Facilities","irWebsite":"http://phx.corporate-ir.net/phoenix.zhtml?c=76556&p=irol-irhome","website":"https://www.davita.com","phone":"720 631 2100"}}